Exploring CCR5 + T regulatory cell subset dysfunction in type 1 diabetes patients: implications for immune regulation
Immunologic Research · 2024
DOI: 10.1007/s12026-024-09508-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunologic Research, 2024. Verfasst von Ławrynowicz Urszula und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland. urszula.lawrynowicz@gumed.edu.pl. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Receptors, CCR5, T-Lymphocytes, Regulatory, Chemokine CCL5. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
T regulatory lymphocytes (Treg) expressing CCR5 exhibit strong suppression activity in various autoimmune disorders. However, there remains a lack of comprehensive understanding regarding their involvement in the development of type 1 diabetes (T1D). In this study, we examined the role of the CCR5/CCL5 axis in regulating inflammatory response and its impact on regulatory T cells in type 1 diabetes (T1D). We hypothesize that dysregulation of the CCR5/CCL5 axis contributes to the development and progression of T1D through modulation of Treg-dependent immune responses. We analyzed the expression levels of CCR5 on Tregs isolated from individuals with T1D, as well as the plasma concentration of its main ligands. We found that Tregs from T1D patients exhibited decreased expression of CCR5 compared to healthy controls. Additionally, we observed a correlation between the expression levels of CCR5 on Tregs and their immunosuppressive function in T1D patients. Our results indicate the impaired migratory capacity of CCR5 + Tregs, suggesting a possible link between the dysregulation of the CCR5/CCL5 axis and impaired immune regulation in T1D. In line with previous studies, our findings support the notion that dysregulation of the CCR5/CCL5 axis contributes to the development and progression of type 1 diabetes (T1D) by modulating Treg-dependent immune responses. The decreased expression of CCR5 on Tregs in T1D patients suggests a potential impairment in the migratory capacity of these cells, which could compromise their ability to suppress autoreactive T cells and maintain immune homeostasis. Furthermore, our study highlights the importance of CCR5 as a biomarker for identifying dysfunctional Tregs in T1D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland. urszula.lawrynowicz@gumed.edu.pl.
- Division of Bioenergetics and Physiology of Exercise, Faculty of Health Sciences, Medical University of Gdańsk, Gdańsk, Poland.
- Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
- Department of Paediatrics, Diabetology and Endocrinology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
Zitieren
APA
Urszula, Ł., Ulana, J., Bartosz, S., Maja, O., Małgorzata, M., & Monika, R. S. (2024). Exploring CCR5 + T regulatory cell subset dysfunction in type 1 diabetes patients: implications for immune regulation. Immunologic Research. https://doi.org/10.1007/s12026-024-09508-2
Vancouver
Urszula Ł, Ulana J, Bartosz S, Maja O, Małgorzata M, Monika RS. Exploring CCR5 + T regulatory cell subset dysfunction in type 1 diabetes patients: implications for immune regulation. Immunologic Research. 2024. doi:10.1007/s12026-024-09508-2
BibTeX
@article{Urszula2024,
author = {Urszula, Ławrynowicz and Ulana, Juhas and Bartosz, Słomiński and Maja, Okońska and Małgorzata, Myśliwiec and Monika, Ryba-Stanisławowska},
title = {Exploring CCR5 + T regulatory cell subset dysfunction in type 1 diabetes patients: implications for immune regulation},
journal = {Immunologic Research},
year = {2024},
doi = {10.1007/s12026-024-09508-2}
}
EUVIMED